Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

Diabetes

Volumn 53, Issue 7, 2004, Pages 1643-1648

  Febbraio, Mark A ^a,b   Hiscock, Natalie ^a,b,c   Sacchetti, Massimo ^b   Fischer, Christian P ^b,c   Pedersen, Bente K ^b,c  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; NORADRENALIN; RECOMBINANT INTERLEUKIN 6;

ADULT; ARTICLE; BICYCLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXERCISE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC CLEARANCE RATE; MUSCLE CONTRACTION; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BICYCLING; EXERCISE; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HOMEOSTASIS; HORMONES; HUMANS; INTERLEUKIN-6; LACTIC ACID; MALE; METABOLIC CLEARANCE RATE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; RECOMBINANT PROTEINS;

EID: 3042721664     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.7.1643     Document Type: Article

References (26)

1. James DE, Kraegen EW, Chisholm DJ: Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. Am J Physiol 248: E575-E580, 1985
2. Kjær M: Hepatic glucose production during exercise. In Skeletal Muscle Metabolism in Exercise and Diabetes. Richter EA, Kiens B, Galbo H, Saltin B, Eds. New York, Plenium, 1998, p. 117-128
3. Wasserman DH, Lacy DB, Colburn CA, Bracy D, Cherrington AD: Efficiency of compensation for absence of fall in insulin during exercise. Am J Physiol Endocrinol Metab 261:E587-E597, 1991
4. Wasserman DH, Spalding JA, Lacy DB, Colburn CA, Goldstein RE, Cherrington AD: Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol Endocrinol Metab 257:E108-E117, 1989
5. Coker RH, Simonsen L, Bulow J, Wasserman DH, Kjæer M: Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component. Am J Physiol Endocrinol Metab 280: E918-E927, 2001
6. Cryer PE: Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol Endocrinol Metab 264:E149-E155, 1993
7. Howlett K, Febbraio M, Hargreaves M: Glucose production during strenuous exercise in humans: role of epinephrine. Am J Physiol Am J Physiol Endocrinol Metab 276:E1130-E1135, 1999
8. Howlett K, Galbo H, Lorentsen J, Bergeron R, Zimmerman-Belsing T, Bülow J, Feldt-Rasmussen U, Kjaer M: Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans. J Physiol 519:911-921, 1999
9. Sigal RJ, Purdon C, Vranic M, Bilinski D, Halter JB, Marliss EB: Glucoregulation during and after intense exercise: effects of beta blockade. J Clin Endocrinol Metab 78:359-366, 1994
10. Sigal RJ, Fisher SJ, Manzon A, Morais JA, Halter JB, Vranic M, Marliss EB: Glucoregulation during and after intense exercise: effects of alpha-adrenergic blockade. Metabolism 49:386-394, 2000
11. Howlett KF, Watt MJ, Hargreaves M, Febbraio MA: Regulation of glucose kinetics during intense exercise in humans: effects of α- and β-adrenergic blockade. Metabolism 52:1615-1620, 2003
12. Kreisman SH, Halter JB, Vranic M, Marliss EB: Combined infusion of epinephrine and norepinephrine during moderate exercise reproduces the glucoregulatory response of intense exercise. Diabetes 52:1347-1354, 2003
13. Goldstein MS: Humoral nature of hypoglycemia in muscular activity. Am J Physiol 200:67-70, 1961
14. Febbraio MA, Pedersen BK: Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16:1335-1347, 2002
15. Pedersen BK, Steensberg A, Schjerling P: Muscle-derived interleukin-6: possible biological effects. J Physiol 15:329-337, 2001
16. Gleeson M: Interleukins and exercise (Commentary). J Physiol 529:1, 2000
17. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK: Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 17:884-886, 2003
18. Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK: Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548:631-638, 2003
19. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005-3010, 2003
20. Steele R, Wall JS, Debodo RC, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotopic dilution method. Am J Physiol 187:15-24, 1956
21. Helge JW, Stallknecht B, Pedersen BK, Galbo H, Kiens B, Richter EA: The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol 546:299-305, 2003
22. Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T: Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:1296-1303, 1998
23. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP: Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82:4167-4170, 1997
24. Saltin B, Gollnick PD: Fuel for muscular exercise: role of carbohydrate. In Exercise Nutrition and Energy Metabolism. Horton ES, Terjung RL, Eds. New York, Macmillan, 1988, p. 45-71
25. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52:2784-2789, 2002
26. Stouthard JM, Oude Elferink RP, Sauerwein HP: Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 220:241-245, 1996